Coronado Research

Key insights from the World Evidence, Pricing, and Access Congress 2025... Some of the Coronado Research Market Access and HEOR team recently attended the World Evidence, Pricing, and Access Congress (WEPA) 2025 in Amsterdam, the Netherlands. The congress was held over two days and attended by over 1,500 people, with 120 exhibitors. In our latest blog, they summarise takeaways from the Congress and the key trends that were discussed. Highlights included discussions on the role of artificial intelligence (AI) in market access, challenges in improving access to orphan drugs, and navigating the EU Joint Clinical Assessment (JCA). You can read the blog here: https://lnkd.in/ezWa6t9w Coronado Research is actively working in all of these areas, and if you would like to find out more about working with our Market Access and HEOR team, e-mail us to arrange a call with one of our experts [email protected] or contact us via our website: https://lnkd.in/eCJyAE2T

Coronado Research Announce Appointment of Nick Littlebury as EVP Regulatory Affairs... Coronado Research has appointed Nicholas L. as EVP, Regulatory Affairs. Nick is a senior regulatory leader with extensive strategic and operational experience across the pharmaceutical industry's product lifecycle. He has previously led regulatory groups in the UK and Europe and has been responsible for developing and executing global client solutions focusing on innovation.    Coronado Research CEO Andrew MacGarvey said, "Nick brings a wealth of regulatory knowledge and a passion for regulatory affairs transformation that aligns perfectly with the Coronado mission. His focus on cross-functional collaboration will enable integrated delivery solutions for our clients. He can draw on experience from positions within the Sponsor, Regulatory Authority, and service provision spaces to build optimised solutions for our customers. Regulatory Affairs plays an important role in the Coronado proposition, and I look forward to working with Nick."   Nick Littlebury commented, "Regulatory Affairs is constantly evolving, and companies continually assess the best way to navigate the regulatory landscape. Coronado's foresight in combining science and technology with humans in the loop is unique. Andrew has assembled an industry-leading team that provides best-in-class solutions across clinical development, market access, medical affairs, and regulatory, integrating technology expertise to optimise the drug development pathway. Artificial Intelligence (AI) and automation advancements are reshaping how we work. We will support companies in unlocking the full potential of these technologies to reduce regulatory burden, helping them focus on what matters most - the patient." About Coronado Research Coronado Research is a consultancy-led, professional services organisation, which provides support to pharmaceutical, biotechnology, and medical device companies. Our objective is to optimise the clinical development process by leveraging all the data available using AI, ML, and leading technologies. Our practices cover Regulatory Strategy, Advanced Analytics, Market Access and Health Economics, and Technology. Our teams work with customers to “join-the-dots” between these disciplines to ensure treatments are developed with the end in mind and better match market needs. For further information please e-mail: [email protected] or contact us via our website: https://lnkd.in/eCJyAE2T

Coronado Research Announce Appointment of Nick Littlebury as EVP Regulatory Affairs... Coronado Research has appointed Nicholas L. as EVP, Regulatory Affairs. Nick is a senior regulatory leader with extensive strategic and operational experience across the pharmaceutical industry's product lifecycle. He has previously led regulatory groups in the UK and Europe and has been responsible for developing and executing global client solutions focusing on innovation.    Coronado Research CEO Andrew MacGarvey said, "Nick brings a wealth of regulatory knowledge and a passion for regulatory affairs transformation that aligns perfectly with the Coronado mission. His focus on cross-functional collaboration will enable integrated delivery solutions for our clients. He can draw on experience from positions within the Sponsor, Regulatory Authority, and service provision spaces to build optimised solutions for our customers. Regulatory Affairs plays an important role in the Coronado proposition, and I look forward to working with Nick."   Nick Littlebury commented, "Regulatory Affairs is constantly evolving, and companies continually assess the best way to navigate the regulatory landscape. Coronado's foresight in combining science and technology with humans in the loop is unique. Andrew has assembled an industry-leading team that provides best-in-class solutions across clinical development, market access, medical affairs, and regulatory, integrating technology expertise to optimise the drug development pathway. Artificial Intelligence (AI) and automation advancements are reshaping how we work. We will support companies in unlocking the full potential of these technologies to reduce regulatory burden, helping them focus on what matters most - the patient." About Coronado Research Coronado Research is a consultancy-led, professional services organisation, which provides support to pharmaceutical, biotechnology, and medical device companies. Our objective is to optimise the clinical development process by leveraging all the data available using AI, ML, and leading technologies. Our practices cover Regulatory Strategy, Advanced Analytics, Market Access and Health Economics, and Technology. Our teams work with customers to “join-the-dots” between these disciplines to ensure treatments are developed with the end in mind and better match market needs. For further information please e-mail: [email protected] or contact us via our website: https://lnkd.in/eCJyAE2T

We are delighted to be #hiring. Apply today or please share this post with your network. Contact us on +442089850565 or [email protected] if you want to discuss careers with our experts.

We’re all ready to go at the Royal Sonesta for our event being hosted jointly by Coronado Research and CluePoints. It’s going to be a great afternoon of lively discussions on the topics of data stewardship, innovations in trial design, and RBQM.

There's still time to join us... We're looking forward to our event this afternoon in Boston, hosted with CluePoints, at the Royal Sonesta. Starting at 3pm, we will be discussing data stewardship, RBQM, and Coronado Research's CSO, Professor Jennifer Visser-Rogers, will be giving a presentation on how technology and novel methodologies are changing the trial design landscape. If you can't make it in time for our speakers, feel free to join us after that for drinks and networking. The event runs until 7pm. You can register for the event here: https://lnkd.in/e_BnG2im

Coronado In Focus: Enhancing Risk-Based Quality Management with a Data-Driven Approach... Part II: Taking the Burden out of RBQM Implementation In our latest Coronado Research In Focus blog post, we're taking a look at the implementation of RBQM. We know that organisations want to use risk-based quality management, so we take a look at how you can overcome the barriers and increase potential efficiencies from ensuring that efforts are concentrated in the right places, particularly for those smaller companies who don’t benefit from the volume savings. You can read the blog here: https://lnkd.in/eYXA4Txh At Coronado Research we can help organisations simplify and implement effective risk-based quality management processes. Our consultancy services, backed by years of experience and expertise, can guide you through each step, ensuring a smooth and successful implementation. Contact us today to learn more about how we can support your risk management journey: https://lnkd.in/eCJyAE2T

We are delighted to be #hiring. Apply today or please share this post with your network. Contact us on +442089850565 or [email protected] if you want to discuss careers with our experts.

We are delighted to be #hiring. Apply today or please share this post with your network. Contact us on +442089850565 or [email protected] if you want to discuss careers with our experts.

Coronado-led research from ACDM25... Members of the Coronado Research team attended ACDM25 in Prague last week and carried out their own research to understand attitudes towards data strategy and technology. We asked thought leaders and innovators in the field of Clinical Data Management several questions aimed at establishing patterns in the current landscape, including questions around current challenges, data strategy, and the use of AI and technology solutions. You can read the results of this research here: https://lnkd.in/ejT9wcbi At Coronado Research we can help organisations simplify and implement effective AI and technology solutions, and guide you on your data strategy to ensure you maximise your data quality and your return on investment. Our consultancy services, backed by years of experience and expertise, can guide you through each step, ensuring a smooth and successful implementation. Contact us today to learn more about how we can support your data and technology: https://lnkd.in/eCJyAE2T